HK Stock MarketDetailed Quotes

CH BIOTECH SER (08037)

Watchlist

0.740
+0.030+4.23%

Market Closed Jan 16 15:58 CST

722.04MMarket Cap-4.81P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CH BIOTECH SER (08037) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Turnover

19.79%38.87M

-66.74%70.51M

-82.21%32.45M

-88.55%211.99M

-84.27%200.71M

-73.45%182.36M

-66.01%130.56M

196.83%1.85B

152.42%1.28B

83.59%686.91M

Operating income

19.79%38.87M

-66.74%70.51M

-82.21%32.45M

-88.55%211.99M

-84.27%200.71M

-73.45%182.36M

-66.01%130.56M

196.83%1.85B

152.42%1.28B

83.59%686.91M

Cost of sales

-2.18%-36.33M

57.53%-75.45M

70.62%-35.56M

76.33%-177.66M

72.05%-150.79M

63.55%-121.03M

58.12%-81.4M

-182.45%-750.58M

-154.70%-539.44M

-110.66%-332.01M

Operating expenses

-2.18%-36.33M

57.53%-75.45M

70.62%-35.56M

76.33%-177.66M

72.05%-150.79M

63.55%-121.03M

58.12%-81.4M

-182.45%-750.58M

-154.70%-539.44M

-110.66%-332.01M

Gross profit

181.82%2.54M

-114.39%-4.94M

-105.07%-3.11M

-96.88%34.32M

-93.22%49.92M

-82.72%61.33M

-74.09%49.16M

207.51%1.1B

150.78%736.31M

63.88%354.9M

Selling expenses

44.56%-3.63M

19.41%-11.77M

10.01%-6.55M

-6.44%-14.61M

-4.09%-10.61M

32.06%-7.28M

4.74%-3.72M

-17.08%-13.73M

-11.87%-10.19M

-74.63%-10.71M

Administrative expenses

52.06%-33.98M

4.98%-131.45M

8.85%-70.88M

42.63%-138.34M

30.99%-108.73M

17.12%-77.77M

17.71%-44.72M

-53.52%-241.16M

-49.38%-157.56M

-47.69%-93.83M

Research and development expenses

66.09%-5.97M

----

---17.59M

----

Revaluation surplus

----

453.58%2.71M

--2.71M

-Changes in the fair value of financial assets

----

453.58%2.71M

--2.71M

Impairment and provision

----

86.47%-684K

----

-195.04%-5.06M

----

-582.87%-1.71M

--859K

----

-Other impairment is provision

----

86.47%-684K

----

-195.04%-5.06M

----

-582.87%-1.71M

--859K

----

Special items of operating profit

182.12%21.73M

245.40%5.8M

-155.63%-26.46M

-185.99%-3.99M

-1,403.46%-13.89M

-367.33%-10.35M

-807.50%-1.82M

1,961.78%4.64M

-311.44%-924K

897.94%3.87M

Operating profit

84.50%-19.31M

-12.04%-143.05M

-265.71%-124.59M

-114.99%-127.67M

-114.58%-83.31M

-113.26%-34.07M

-100.82%-1.09M

349.03%851.71M

218.29%571.21M

74.46%256.95M

Financing cost

-167.52%-12.54M

-218.62%-16.92M

-75.70%-4.69M

-51.96%-5.31M

-20.77%-3.94M

-15.45%-2.67M

-11.18%-1.35M

46.58%-3.5M

38.35%-3.26M

43.33%-2.31M

Share of profit from joint venture company

----

-83.68%-7.68M

-211.87%-7.67M

-168.51%-2.77M

---1.49M

---4.18M

---2.46M

---1.03M

Special items of earning before tax

-276.23%-5.32M

-6,715.49%-92.83M

-79.66%3.02M

-107.25%-1.36M

207.44%14.83M

9,655.26%14.83M

---26K

861.82%18.79M

207.06%4.82M

103.37%152K

Earning before tax

70.57%-37.16M

-77.99%-252.8M

-411.64%-126.26M

-116.46%-142.03M

-114.04%-80.09M

-109.72%-24.68M

-103.00%-3.96M

377.58%862.83M

236.12%570.31M

82.95%253.76M

Tax

-22.96%406K

-28.51%943K

117.31%527K

100.84%1.32M

97.55%-2.61M

93.58%-3.04M

84.99%-3.82M

-226.97%-157.26M

-182.43%-106.7M

-59.51%-47.4M

After-tax profit from continuing operations

70.77%-36.75M

-78.99%-251.85M

-353.56%-125.73M

-119.94%-140.71M

-117.84%-82.7M

-113.43%-27.72M

-107.30%-7.78M

432.21%705.57M

251.51%463.61M

89.34%206.36M

Earning after tax

70.77%-36.75M

-78.99%-251.85M

-353.56%-125.73M

-119.94%-140.71M

-117.84%-82.7M

-113.43%-27.72M

-107.30%-7.78M

432.21%705.57M

251.51%463.61M

89.34%206.36M

Minority profit

89.64%-4.75M

-18.67%-53.71M

-1,758.13%-45.81M

-110.11%-45.26M

-105.50%-16.72M

-98.00%2.76M

-89.40%7.59M

295.35%447.48M

190.61%304.09M

63.00%138.14M

Profit attributable to shareholders

59.95%-32.01M

-107.60%-198.15M

-162.16%-79.92M

-136.98%-95.45M

-141.36%-65.98M

-144.68%-30.48M

-144.01%-15.38M

1,231.37%258.09M

485.29%159.52M

181.45%68.22M

Basic earnings per share

60.24%-0.033

-107.07%-0.205

-159.38%-0.083

-136.94%-0.099

-140.96%-0.068

-145.07%-0.032

-144.44%-0.016

1,240.00%0.268

492.86%0.166

184.00%0.071

Diluted earnings per share

60.24%-0.033

-107.07%-0.205

-159.38%-0.083

-136.94%-0.099

-140.96%-0.068

-145.07%-0.032

-144.44%-0.016

1,240.00%0.268

492.86%0.166

184.00%0.071

Currency Unit

HKD

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Rosenmei Certified Public Accountants

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Turnover	19.79%38.87M	-66.74%70.51M	-82.21%32.45M	-88.55%211.99M	-84.27%200.71M	-73.45%182.36M	-66.01%130.56M	196.83%1.85B	152.42%1.28B	83.59%686.91M
Operating income	19.79%38.87M	-66.74%70.51M	-82.21%32.45M	-88.55%211.99M	-84.27%200.71M	-73.45%182.36M	-66.01%130.56M	196.83%1.85B	152.42%1.28B	83.59%686.91M
Cost of sales	-2.18%-36.33M	57.53%-75.45M	70.62%-35.56M	76.33%-177.66M	72.05%-150.79M	63.55%-121.03M	58.12%-81.4M	-182.45%-750.58M	-154.70%-539.44M	-110.66%-332.01M
Operating expenses	-2.18%-36.33M	57.53%-75.45M	70.62%-35.56M	76.33%-177.66M	72.05%-150.79M	63.55%-121.03M	58.12%-81.4M	-182.45%-750.58M	-154.70%-539.44M	-110.66%-332.01M
Gross profit	181.82%2.54M	-114.39%-4.94M	-105.07%-3.11M	-96.88%34.32M	-93.22%49.92M	-82.72%61.33M	-74.09%49.16M	207.51%1.1B	150.78%736.31M	63.88%354.9M
Selling expenses	44.56%-3.63M	19.41%-11.77M	10.01%-6.55M	-6.44%-14.61M	-4.09%-10.61M	32.06%-7.28M	4.74%-3.72M	-17.08%-13.73M	-11.87%-10.19M	-74.63%-10.71M
Administrative expenses	52.06%-33.98M	4.98%-131.45M	8.85%-70.88M	42.63%-138.34M	30.99%-108.73M	17.12%-77.77M	17.71%-44.72M	-53.52%-241.16M	-49.38%-157.56M	-47.69%-93.83M
Research and development expenses	66.09%-5.97M	----	---17.59M	----	----	----	----	----	----	----
Revaluation surplus	----	----	----	----	----	----	----	453.58%2.71M	--2.71M	--2.71M
-Changes in the fair value of financial assets	----	----	----	----	----	----	----	453.58%2.71M	--2.71M	--2.71M
Impairment and provision	----	86.47%-684K	----	-195.04%-5.06M	----	----	----	-582.87%-1.71M	--859K	----
-Other impairment is provision	----	86.47%-684K	----	-195.04%-5.06M	----	----	----	-582.87%-1.71M	--859K	----
Special items of operating profit	182.12%21.73M	245.40%5.8M	-155.63%-26.46M	-185.99%-3.99M	-1,403.46%-13.89M	-367.33%-10.35M	-807.50%-1.82M	1,961.78%4.64M	-311.44%-924K	897.94%3.87M
Operating profit	84.50%-19.31M	-12.04%-143.05M	-265.71%-124.59M	-114.99%-127.67M	-114.58%-83.31M	-113.26%-34.07M	-100.82%-1.09M	349.03%851.71M	218.29%571.21M	74.46%256.95M
Financing cost	-167.52%-12.54M	-218.62%-16.92M	-75.70%-4.69M	-51.96%-5.31M	-20.77%-3.94M	-15.45%-2.67M	-11.18%-1.35M	46.58%-3.5M	38.35%-3.26M	43.33%-2.31M
Share of profit from joint venture company	----	----	----	-83.68%-7.68M	-211.87%-7.67M	-168.51%-2.77M	---1.49M	---4.18M	---2.46M	---1.03M
Special items of earning before tax	-276.23%-5.32M	-6,715.49%-92.83M	-79.66%3.02M	-107.25%-1.36M	207.44%14.83M	9,655.26%14.83M	---26K	861.82%18.79M	207.06%4.82M	103.37%152K
Earning before tax	70.57%-37.16M	-77.99%-252.8M	-411.64%-126.26M	-116.46%-142.03M	-114.04%-80.09M	-109.72%-24.68M	-103.00%-3.96M	377.58%862.83M	236.12%570.31M	82.95%253.76M
Tax	-22.96%406K	-28.51%943K	117.31%527K	100.84%1.32M	97.55%-2.61M	93.58%-3.04M	84.99%-3.82M	-226.97%-157.26M	-182.43%-106.7M	-59.51%-47.4M
After-tax profit from continuing operations	70.77%-36.75M	-78.99%-251.85M	-353.56%-125.73M	-119.94%-140.71M	-117.84%-82.7M	-113.43%-27.72M	-107.30%-7.78M	432.21%705.57M	251.51%463.61M	89.34%206.36M
Earning after tax	70.77%-36.75M	-78.99%-251.85M	-353.56%-125.73M	-119.94%-140.71M	-117.84%-82.7M	-113.43%-27.72M	-107.30%-7.78M	432.21%705.57M	251.51%463.61M	89.34%206.36M
Minority profit	89.64%-4.75M	-18.67%-53.71M	-1,758.13%-45.81M	-110.11%-45.26M	-105.50%-16.72M	-98.00%2.76M	-89.40%7.59M	295.35%447.48M	190.61%304.09M	63.00%138.14M
Profit attributable to shareholders	59.95%-32.01M	-107.60%-198.15M	-162.16%-79.92M	-136.98%-95.45M	-141.36%-65.98M	-144.68%-30.48M	-144.01%-15.38M	1,231.37%258.09M	485.29%159.52M	181.45%68.22M
Basic earnings per share	60.24%-0.033	-107.07%-0.205	-159.38%-0.083	-136.94%-0.099	-140.96%-0.068	-145.07%-0.032	-144.44%-0.016	1,240.00%0.268	492.86%0.166	184.00%0.071
Diluted earnings per share	60.24%-0.033	-107.07%-0.205	-159.38%-0.083	-136.94%-0.099	-140.96%-0.068	-145.07%-0.032	-144.44%-0.016	1,240.00%0.268	492.86%0.166	184.00%0.071
Currency Unit	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--
Auditor	--	--	--	Rosenmei Certified Public Accountants	--	--	--	Rosenmei Certified Public Accountants	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?